Eplerenone trial stopped early after reaching its primary endpoint, Pfizer announces « CardioBrief
Links shared publicly online about this topic.
- 1,138total visits
Eplerenone trial stopped early after reaching its primary endpoint, Pfizer announces « CardioBrief
Eplerenone trial stopped early after reaching its primary endpoint, Pfizer announces « CardioBrief
View full resource at cardiobrief.org
Tags: Pfizer
Most Recently Shared on June 5, 2010 at 2:26 am By:
Stephen L. Sigal, MD, MS, FACC, FAHA
Pfizer stops EMPHASIS-HF trial early: Eplerenone decreased CV death and heart failure admissions in pts with mild HF http://bit.ly/dqc1EZ
Advertisement
